Open AccessLack of Primary Mutations Associated With Integrase Inhibitors Among HIV-1 Subtypes B, C, and F Circulating in Brazil
Author(s) -
Caroline Passaes,
Monick Lindenmeyer Guimarães,
Saada Lima Chequer Fernandez,
Roberta dos Santos Lorete,
Sylvia Lopes Maia Teixeira,
José Carlos Couto-Fernandez,
Mariza G. Morgado
Publication year - 2009
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e31819df3b3
Subject(s) - elvitegravir , raltegravir , integrase , virology , integrase inhibitor , biology , drug resistance , resistance mutation , reverse transcriptase , mutation , lentivirus , polymerase chain reaction , genetics , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , gene , viral disease
Antiretroviral drugs targeting integrase (IN) have recently been approved for use in combined and salvage therapeutic interventions.